JAMA Oncology Author Interviews
624 FOLLOWERS
Interviews with authors of articles from JAMA Oncology. JAMA Oncology is the definitive journal for scientists, clinicians, and trainees in the field of oncology worldwide. It aims to effectively convey the findings of important clinical research, major scientific breakthroughs, actionable discoveries, and state-of-the-art treatment pathways to the oncology community.
JAMA Oncology Author Interviews
6d ago
Interview with Hagop Kantarjian, MD, author of Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib: A Phase 1b Randomized Clinical Trial. Hosted by Vivek Subbiah, MD.
Related Content:
Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib ..read more
JAMA Oncology Author Interviews
1M ago
Interview with Maria E. Cabanillas, MD, author of Anti–Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma: A Nonrandomized Clinical Trial. Hosted by Vivek Subbiah, MD.
Related Content:
Anti–Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma ..read more
JAMA Oncology Author Interviews
1M ago
Interview with Roni Shouval, MD, PhD, author of T-Cell Malignant Neoplasms After Chimeric Antigen Receptor T-Cell Therapy. Hosted by Vivek Subbiah, MD.
Related Content:
T-Cell Malignant Neoplasms After Chimeric Antigen Receptor T-Cell Therapy ..read more
JAMA Oncology Author Interviews
2M ago
Interview with Eileen M. O’Reilly, MD, author of Lynch Syndrome and Somatic Mismatch Repair Variants in Pancreas Cancer. Hosted by Vivek Subbiah, MD.
Related Content:
Lynch Syndrome and Somatic Mismatch Repair Variants in Pancreas Cancer ..read more
JAMA Oncology Author Interviews
3M ago
Interview with Michelle Rengarajan, MD, PhD, author of Identification of Immune Checkpoint Inhibitor–Induced Diabetes. Hosted by Vivek Subbiah, MD.
Related Content:
Identification of Immune Checkpoint Inhibitor–Induced Diabetes ..read more
JAMA Oncology Author Interviews
4M ago
Interview with Lee W. Jones, PhD, author of Neoadjuvant Exercise Therapy in Prostate Cancer: A Phase 1, Decentralized Nonrandomized Controlled Trial. Hosted by Vivek Subbiah, MD. Related Content:
Neoadjuvant Exercise Therapy in Prostate Cancer ..read more
JAMA Oncology Author Interviews
5M ago
Interview with Kemi M. Doll, MD, MSCR, author of Endometrial Thickness as Diagnostic Triage for Endometrial Cancer Among Black Individuals. Hosted by Vivek Subbiah, MD. Related Content:
Endometrial Thickness as Diagnostic Triage for Endometrial Cancer Among Black Individuals ..read more
JAMA Oncology Author Interviews
8M ago
Interview with Tobias Janowitz, MD, PhD, and Karen Winkfield, MD, PhD, authors of Analysis and Optimization of Equitable US Cancer Clinical Trial Center Access by Travel Time. Hosted by Vivek Subbiah, MD. Related Content:
Analysis and Optimization of Equitable US Cancer Clinical Trial Center Access by Travel Time ..read more
JAMA Oncology Author Interviews
9M ago
Interview with José P. Leone, MD, author of Mortality Risks Over 20 Years in Men With Stage I to III Hormone Receptor–Positive Breast Cancer. Hosted by Nora L. (Mary) Disis, MD. Related Content:
Mortality Risks Over 20 Years in Men With Stage I to III Hormone Receptor–Positive Breast Cancer ..read more
JAMA Oncology Author Interviews
11M ago
Interview with Sajid A. Khan, MD, author of Immunotherapy Initiation at the End of Life in Patients With Metastatic Cancer in the US. Hosted by Mary L. (Nora) Disis, MD. Related Content:
Immunotherapy Initiation at the End of Life in Patients With Metastatic Cancer in the US ..read more